Projects By Category: Metabolic Disorders
Stay up to date with project updates from the Metabolic Disorders|/projects/category/metabolic-disorders category.Latest Industry Projects in Metabolic Disorders
Developed by Sanofi-Aventis, Acomplia (rimonabant) is a selective CB1 endocannabinoid receptor antagonist indicated for...
> read more
Byetta - First-in-Class Incretin Mimetic
Developed by Amylin Pharmaceuticals, Byetta (exenatide) is a synthetic exendin-4 agent indicated for the treatment of...
Cetilistat - Investigational Drug for Obesity
Developed by Alizyme, a specialist biopharmaceutical company in collaboration with Takeda Pharmaceutical, cetilistat...
Elelyso (Taliglucerase Alfa) for Treating Gaucher Disease
Elelyso (taliglucerase alfa) is an intravenous drug indicated for the treatment of type one Gaucher disease. The drug was jointly developed by Protalix BioTherapeutics and...
Twitter
Facebook